Medically reviewed by Krishna Surapaneni, MD, board-certified ophthalmologist and cataract, cornea, and refractive surgeon at SuraVision in Houston.
Big news arrived for cataract patients on July 6, 2026. Alcon, the world’s largest eye care company, and RxSight, the maker of the Light Adjustable Lens, announced they will work together on a new kind of adjustable lens implant. On the same day, RxSight shared plans for the next generation of its own adjustable lenses.
If you have cataracts, the natural question is simple: should I wait for the new technology?
It is a fair question, and it deserves a straight answer. Here is what was announced, what was not, and how to think about the timing of your own surgery.
What Did Alcon and RxSight Announce?
Two separate things, both on July 6, 2026:
- A collaboration on adjustable presbyopia-correcting lenses. Alcon and RxSight signed a non-exclusive agreement to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). The plan pairs Alcon’s premium lens optics, the family that includes PanOptix and Vivity, with RxSight’s light-adjustment technology, so surgeons could fine-tune a premium lens after surgery.
- RxSight’s next-generation adjustable lens platform. RxSight also announced new versions of its own lenses in development: a next-generation LAL, a next-generation LAL+ for better intermediate vision, and a LAL Toric with built-in astigmatism correction. The company says the new platform aims for improved workflow and fewer required post-operative light treatments.
In plain language: the companies that make today’s most popular premium lenses and today’s only adjustable lens want to bring adjustability to more lens types, with fewer office visits.
What the Announcements Did Not Say
This is where patients need clear eyes, so to speak.
- No release dates. Neither company announced when any of these lenses will be available. The releases describe products in development, not products you can get.
- No FDA approval. None of the next-generation or co-developed lenses is FDA approved. Each will need to complete development and the FDA review process first, and neither company has said how long that will take.
- No clinical results. There is no published patient data on the new lenses yet.
New lens technology in the United States routinely takes years to move from announcement to operating room, and nothing in these releases suggests otherwise. Planning your vision around an unannounced date means planning around a guess.
So Should You Wait?
For most people whose cataracts are already interfering with daily life, waiting for unreleased technology has a real cost. A cataract is your eye’s natural lens turned cloudy, and cataracts generally get worse over time rather than better. Waiting for a lens with no release date means more months or years of the symptoms that brought you here: blurry vision, glare, and trouble driving at night.
Here is the part many patients miss: adjustability is not a future technology. It exists today. The current Light Adjustable Lens has been FDA approved since 2017 and is the only lens implant available in the United States that can be fine-tuned after surgery. You heal first, then your surgeon adjusts the lens with short office light treatments based on how you actually see, not on predictions. Our post on how the Light Adjustable Lens works walks through the full process.
The honest exception: if your cataracts are mild and are not limiting your daily life, there may be no urgency at all, new technology or not. Some patients monitor mild cataracts for years. That is a decision to make with your ophthalmologist after an exam, though, not from a press release.
What This Means at SuraVision
Dr. Sura already performs adjustable-lens cataract surgery with the current Light Adjustable Lens. As next-generation adjustable lenses earn FDA approval and become available, SuraVision plans to adopt them, the same way the practice added the LAL, PanOptix, Vivity, and PureSee as each earned approval.
So this is not a choice between treating your cataracts now and getting adjustability someday. You can compare all of today’s cataract lens options, including an adjustable one, at a consultation now.
Frequently Asked Questions
What did Alcon and RxSight announce on July 6, 2026?
A non-exclusive collaboration to develop adjustable presbyopia-correcting lens implants, combining Alcon’s lens optics with RxSight’s light-adjustment technology. Separately, RxSight announced next-generation versions of its Light Adjustable Lens family in development: a new LAL, LAL+, and LAL Toric.
Is the next-generation Light Adjustable Lens FDA approved?
No. The next-generation lenses and the Alcon collaboration lenses are in development and are not FDA approved. Neither company has announced a release date.
Is the current Light Adjustable Lens still a good choice?
The current Light Adjustable Lens has been FDA approved since 2017 and is used in cataract surgery today. It is the only lens implant available in the United States that can be adjusted after surgery. Whether it fits your eyes is a question for a consultation and a full exam.
Should I delay cataract surgery to wait for new lens technology?
For most people with cataracts that limit daily life, waiting for unreleased technology means living longer with blurry vision, glare, and night-driving trouble while no release date exists. If your cataracts are mild, waiting may be reasonable. Ask your ophthalmologist to walk through the tradeoffs for your eyes.
Will SuraVision offer the next-generation adjustable lenses?
SuraVision already offers the current Light Adjustable Lens and plans to adopt next-generation adjustable lenses as they earn FDA approval and become available.
Talk Through Your Lens Options in Houston
Ready to take the next step toward clearer vision? Schedule a consultation with SuraVision today to discuss cataract surgery and your lens options, including the Light Adjustable Lens. Call us at 713-730-2020 or book your appointment online. Not sure whether cataracts are behind your symptoms? Start with the Cataract Self Test.